Cargando…
Thiazides in chronic kidney disease: “back to the future”
The thiazide class diuretics are first-line agents for managing hypertension either as monotherapy or as a fixed-dose combination with other antihypertensive drugs. However, despite the extensive experience with these drugs for >60 years, there is general reluctance to use these agents in patient...
Autores principales: | de la Espriella, Rafael, Cobo, Marta, Núñez, Julio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871840/ https://www.ncbi.nlm.nih.gov/pubmed/36726428 http://dx.doi.org/10.1093/ckj/sfac228 |
Ejemplares similares
-
Valvular heart disease in patients on kidney replacement therapy: “opening Pandora's box”
por: de la Espriella, Rafael, et al.
Publicado: (2023) -
Drug repurposing in autosomal dominant polycystic kidney disease: back to the future with pioglitazone
por: Mao, Zhiguo, et al.
Publicado: (2021) -
Effectiveness of thiazide and thiazide-like diuretics in advanced chronic kidney disease: a systematic review and meta-analysis
por: Teles, Flávio, et al.
Publicado: (2023) -
The unmet need of evidence-based therapy for patients with advanced chronic kidney disease and heart failure: Position paper from the Cardiorenal Working Groups of the Spanish Society of Nephrology and the Spanish Society of Cardiology
por: Ortiz, Alberto, et al.
Publicado: (2021) -
Thiazide diuretics are back in CKD: the case of chlorthalidone
por: Minutolo, Roberto, et al.
Publicado: (2022)